Empafox Met 12.5/500 Empagliflozin IP (12.5mg) & Metfromin HCI IP (500 mg) Tablets
Empafox Met 12.5/500 Tab is a combination oral antidiabetic medicine composed of Empagliflozin 12.5 mg and Metformin Hydrochloride 500 mg, formulated to help manage type 2 diabetes...
In Stock
Empafox Met 12.5/500 Empagliflozin IP (12.5mg) & Metfromin HCI IP (500 mg) Tablets
Empafox Met 12.5/500 Tab is a combination oral antidiabetic medicine composed of Empagliflozin 12.5 mg and Metformin Hydrochloride 500 mg, formulated to help manage type 2 diabetes mellitus. This dual-action therapy improves glycemic control by reducing glucose production in the liver and promoting its excretion via the kidneys. Doctors often recommend Empafox Met 12.5/500 Tab to adults with uncontrolled diabetes as part of a treatment plan involving proper diet and exercise. If you're looking to buy Empafox Met 12.5/500 tabs online, connect with us.
| Strength | Empagliflozin IP (12.5mg) & Metfromin HCI IP (500 mg) |
| Composition | Empagliflozin+Metformin |
| Packaging Size | 10 tablets |
| Treatment | american remedies healthcare pvt. ltd |
| Prescription Required | Required |